Lv21
136 积分 2024-06-30 加入
Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC
4小时前
已完结
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
1个月前
已完结
Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics
1个月前
已完结
Clinical development of cancer vaccines
1个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
2个月前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
2个月前
已完结
Improving surgical treatments for hepatocellular carcinoma
2个月前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
2个月前
已完结
皖公网安备34019202002308
